Conclusion of non-exclusive rebate agreements pursuant to § 130a Abs. 8 SGB V for the aforementioned active substances with the possibility of conclusion within the framework of the so-called Open-House procedure.
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany
Contract
BuyerKKH Kaufmännische Krankenkasse
TypeSupplies
Estimated valuevalue not published
Published24 November 2023
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| mibe GmbH Arzneimittel · Sandersdorf-Brehna | 8 | 2013–2016 |
| betapharm Arzneimittel GmbH · Augsburg | 8 | 2013–2016 |
| neuraxpharm Arzneimittel GmbH · Langenfeld | 8 | 2013–2016 |
| Basics GmbH · Leverkusen | 8 | 2013–2016 |
| Aliud Pharma GmbH · Laichingen | 8 | 2013–2016 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
201956
202029
202128
202292
2023194
2024208
2025366
2026115
Who knows the rhythm prepares instead of reacting.
134
days until the deadline — Thursday 31 December at 20:59
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →